Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 8 articles:
HTML format



Single Articles


    November 2022
  1. PRADHAN R, Lu S, Yin H, Yu OHY, et al
    Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study.
    BMJ. 2022;379:e071380.
    PubMed     Abstract available


    July 2022
  2. SAFIRI S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, et al
    Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019.
    BMJ. 2022;378:e069679.
    PubMed     Abstract available


    May 2022
  3. SUMILO D, Nirantharakumar K, Willis BH, Rudge GM, et al
    Long term impact of prophylactic antibiotic use before incision versus after cord clamping on children born by caesarean section: longitudinal study of UK electronic health records.
    BMJ. 2022;377:e069704.
    PubMed     Abstract available


    March 2022
  4. SAUL H, Gursul D, Cassidy S, Hinks T, et al
    Combination inhaler is effective in mild asthma.
    BMJ. 2022;376:o663.
    PubMed     Abstract available


    December 2021
  5. MAHASE E
    Covid-19: Poorly controlled asthma increases risk of hospital admission among children sixfold, finds study.
    BMJ. 2021;375:n2959.
    PubMed    


    October 2021
  6. FRIEDMAN JN, Davis T, Somaskanthan A, Ma A, et al
    Avoid doing chest x rays in infants with typical bronchiolitis.
    BMJ. 2021;375:e064132.
    PubMed    


  7. WISE J
    NICE approves monoclonal antibody dupilumab for severe asthma.
    BMJ. 2021;375:n2546.
    PubMed    


  8. O'CARROLL O, McCarthy C, Butler MW
    Treatments for poorly controlled asthma.
    BMJ. 2021;375:n2355.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: